e-Drug3D

716

MOEXIPRIL


INN
MOEXIPRIL

(has an active metabolite)

cas 103775-10-6
CLASS

CARDIOVASCULAR
ANTIHYPERTENSIVE
ANGIOTENSIN CONVERTING ENZYME INHIBITORS

ROUTE (list)

ORAL

ATC code

C09AA13
C09BA13

PK parameters

F 13 PERCENT
Cl 26.4 LITER / HOUR

Solubility

SOLUBLE IN WATER


Target

TARGET ANGIOTENSIN CONVERTING ENZYME (ACE)
KININASE II

DrugCentral

Angiotensin-converting enzyme UNIPROT P12821 ACE

Download SDF file (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid

Formula:
C27H34N2O7

Calculated chemical properties:

MW 497.55
NB_atoms 36
XLogP 1.25
PSA 108.573
NB_HD 1
NB_HA 9
fsp3 0.44
Lipinski(0=no;1=yes) 1

FDA
NDA 020312 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) UNIVASC (UCB INC) APPROVAL= AP YEAR= 1995 DISCONTINUED
NDA 020729 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) UNIRETIC (UCB INC) APPROVAL= AP YEAR= 1997 DISCONTINUED
NDA 076204 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (TEVA) APPROVAL= AP YEAR= 2003
NDA 077536 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2006
NDA 076980 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (TEVA) APPROVAL= AP YEAR= 2007
NDA 078454 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (APOTEX INC) APPROVAL= AP YEAR= 2008 DISCONTINUED
NDA 090096 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2008 DISCONTINUED
NDA 090416 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2010
NDA 090718 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (GLENMARK PHARMS) APPROVAL= AP YEAR= 2010
NDA 202150 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HERITAGE PHARMS) APPROVAL= AP YEAR= 2014 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL